The less profits pharmaceutical companies make, the more sales management expenses need to be spent

It is known that mid-sized pharmaceutical companies between KRW 100 billion and KRW 200 billion sales made soundest growth last year. They actualized profits proportional to sales growth. On the other hand, large pharmaceutical companies did not make enough profits against how they appeared.

Moreover, pharmaceutical companies having less than KRW 100 billion sales showed decreases in profits. ...